DexCom, Inc. - Common Stock (NQ:DXCM)

67.26 -0.21 (-0.31%)

Streaming Delayed Price Updated: 3:07 PM EST, Dec 30, 2025 Add to My Watchlist

Price and Volume

Volume	1,124,947
Open	67.36
Bid (Size)	67.24 (100)
Ask (Size)	67.27 (200)
Prev. Close	67.47
Today's Range	66.86 - 67.71
52wk Range	54.11 - 93.25
Shares Outstanding	390,000,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

2 Growth Stocks to Buy For 2026 and Beyond ↗

Today 8:20 EST

Neither had a great year in 2025, but the future is looking bright.

Via The Motley Fool

DexCom Inc (NASDAQ:DXCM) Embodies the Growth at a Reasonable Price (GARP) Strategy ↗

Today 5:11 EST

DexCom (DXCM) exemplifies Growth at a Reasonable Price (GARP) with strong double-digit earnings growth, solid profitability, and a valuation justified by its industry-leading position in diabetes...

Via Chartmill

Performance

YTD	-14.3%	-14.3%
1 Month	+5.9%	+5.9%
3 Month	+1.2%	+1.2%
6 Month	-22.9%	-22.9%
1 Year	-13.8%	-13.8%

More News

DEXCOM CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds DXCM Investors of the December 26th Deadline for Contacting the Firm

December 26, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

December 26, 2025

From Schall Law

Via GlobeNewswire

The $65 Billion Pulse: How Wearable AI and Telemedicine are Redefining the Future of Healthcare

December 24, 2025

Via MarketMinute

1 Cash-Heavy Stock for Long-Term Investors and 2 We Avoid

December 22, 2025

Via StockStory

DEXCOM CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds DXCM Investors of the December 26th Deadline for Contacting the Firm

December 22, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

DXCM Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Investors of Filing Deadline in Class Action Lawsuit

December 22, 2025

Via TheNewswire.com

DXCM Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Investors of Filing Deadline in Class Action Lawsuit

December 22, 2025

Via NewMediaWire

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

December 22, 2025

From Schall Law

Via GlobeNewswire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (NASDAQ: DXCM)

December 22, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

DexCom Inc (NASDAQ:DXCM): A High-Growth Stock Forming a Bullish Technical Setup ↗

December 19, 2025

Via Chartmill

1 Cash-Producing Stock with Impressive Fundamentals and 2 We Ignore

December 18, 2025

Via StockStory

Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights

December 18, 2025

From Halper Sadeh LLC

Via GlobeNewswire

DXCM DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Dexcom, Inc. (DXCM) Securities Fraud Class Action Lawsuit

December 18, 2025

Via NewMediaWire

DXCM DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Dexcom, Inc. (DXCM) Securities Fraud Class Action Lawsuit

December 18, 2025

Via TheNewswire.com

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

December 18, 2025

From Schall Law

Via GlobeNewswire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (NASDAQ: DXCM)

December 17, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DexCom and CarMax and Encourages Investors to Contact the Firm

December 16, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

DXCM DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important December 29 Deadline in Securities Class Action – DXCM

December 16, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

“Buying the Dip” in 2025: A Strategy Rewarded, But Future Requires Caution and Diversification

December 16, 2025

Via MarketMinute

DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces That DexCom, Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit

December 15, 2025

Via NewMediaWire

DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces That DexCom, Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit

December 15, 2025

Via TheNewswire.com

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

December 15, 2025

From Schall Law

Via GlobeNewswire

DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT Bernstein Liebhard LLP Reminds DexCom, Inc. Investors of Upcoming Deadline

December 15, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

Frequently Asked Questions

Is DexCom, Inc. - Common Stock publicly traded?

Yes, DexCom, Inc. - Common Stock is publicly traded.

What exchange does DexCom, Inc. - Common Stock trade on?

DexCom, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for DexCom, Inc. - Common Stock?

The ticker symbol for DexCom, Inc. - Common Stock is DXCM on the Nasdaq Stock Market

What is the current price of DexCom, Inc. - Common Stock?

The current price of DexCom, Inc. - Common Stock is 67.26

When was DexCom, Inc. - Common Stock last traded?

The last trade of DexCom, Inc. - Common Stock was at 12/30/25 03:07 PM ET

What is the market capitalization of DexCom, Inc. - Common Stock?

The market capitalization of DexCom, Inc. - Common Stock is 26.23B

How many shares of DexCom, Inc. - Common Stock are outstanding?

DexCom, Inc. - Common Stock has 26B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.